UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children

AIDS (London), 2007-05, Vol.21 (8), p.947-955

2007

Link zum Volltext

Verfügbarkeit prüfen

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1441-1449

2009

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

Journal of acquired immune deficiency syndromes (1999), 2012-04, Vol.59 (5), p.489

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

Antiviral therapy, 2010-01, Vol.15 (3), p.297-305

2010

Link zum Volltext

Verfügbarkeit prüfen

Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions

AIDS (London), 2013-02, Vol.27 (4), p.579-589

2013

Link zum Volltext

Verfügbarkeit prüfen

Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors

Epidemiology (Cambridge, Mass.), 2008-05, Vol.19 (3), p.391-400

2008

Link zum Volltext

Verfügbarkeit prüfen

Ambient Air Pollution and Daily Mortality Among Survivors of Myocardial Infarction

Epidemiology (Cambridge, Mass.), 2009-01, Vol.20 (1), p.110-118

2009

Link zum Volltext

Verfügbarkeit prüfen

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial

The Pediatric infectious disease journal, 2003-01, Vol.22 (1), p.56-62

2003

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

AIDS (London), 2006-11, Vol.20 (17), p.2183-2191

2006

Link zum Volltext

Verfügbarkeit prüfen

Fibrinogen Genes Modify the Fibrinogen Response to Ambient Particulate Matter

American journal of respiratory and critical care medicine, 2009-03, Vol.179 (6), p.484-491

2009

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and toddlers

British journal of clinical pharmacology, 2012-04, Vol.73 (4), p.641-650

2012

Link zum Volltext

Verfügbarkeit prüfen

Response to planned treatment interruptions in HIV infection varies across childhood

AIDS (London), 2010-01, Vol.24 (2), p.231-241

EUROPEAN, Paediatric

2010

Link zum Volltext

Verfügbarkeit prüfen

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment

Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1223-1232

2009

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy outcomes in women with HIV type―1 receiving a lopinavir/ritonavir―containing regimen

Antiviral therapy, 2009-01, Vol.14 (3), p.423-432

2009

Link zum Volltext

Verfügbarkeit prüfen

DNA variants, plasma levels and variability of Interleukin-6 in myocardial infarction survivors: Results from the AIRGENE study

Thrombosis research, 2009-05, Vol.124 (1), p.57-64

2009

Link zum Volltext

Verfügbarkeit prüfen

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

Antiviral therapy, 2004-06, Vol.9 (3), p.415-421

2004

Link zum Volltext

Verfügbarkeit prüfen

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Clinical infectious diseases, 2002-03, Vol.34 (5), p.649-657

2002

Link zum Volltext

Verfügbarkeit prüfen

Impact of Human Immunodeficiency Virus Type 1 Subtypes on Virologic Response and Emergence of Drug Resistance among Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial

The Journal of infectious diseases, 2002-09, Vol.186 (5), p.617-625

2002

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

The Pediatric infectious disease journal, 2003-01, Vol.22 (1), p.48-55

2003

Link zum Volltext

Verfügbarkeit prüfen

Bayesian Parameter Estimates of Nelfinavir and Its Active Metabolite, Hydroxy-tert-Butylamide, in Infants Perinatally Infected with Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy, 2005-02, Vol.49 (2), p.525-535

2005

Link zum Volltext

Verfügbarkeit prüfen

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse-Transcriptase Inhibitors in HIV Type 1–Infected Children

Clinical infectious diseases, 2008-05, Vol.46 (10), p.1601-1608

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the conventional ‘box technique’ with two different ‘conformal’ beam arrangements for prostate cancer treatment

Cancer radiothérapie, 1999-05, Vol.3 (3), p.215-220

1999

Link zum Volltext

Verfügbarkeit prüfen

Increased Thymic Output after Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus Type 1–Infected Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial

The Journal of infectious diseases, 2002-08, Vol.186 (3), p.312-320

2002

Link zum Volltext

Verfügbarkeit prüfen

Association Analysis of Drug Metabolizing Enzyme Gene Polymorphisms in AIDS Patients with Cutaneous Reactions to Sulfonamides

Journal of investigative dermatology, 2005-11, Vol.125 (5), p.1080-1082

2005

Link zum Volltext

Verfügbarkeit prüfen

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial)

Antiviral therapy, 2002-12, Vol.7 (4), p.293-303

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(45)
Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Humans
(41)
Infectious Diseases
(29)
Female
(25)
Male
(25)
Pharmacology. Drug Treatments
(24)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(20)
Viral Diseases
(19)
Hiv Infections - Drug Therapy
(18)
Human Viral Diseases
(18)
Antiviral Agents
(16)
Immunology
(16)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(16)
Adult
(14)
Virology
(14)
Immunopathology
(12)
Microbiology
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions

Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors

Ambient Air Pollution and Daily Mortality Among Survivors of Myocardial Infarction

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

Fibrinogen Genes Modify the Fibrinogen Response to Ambient Particulate Matter

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and toddlers

Response to planned treatment interruptions in HIV infection varies across childhood

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment

Pregnancy outcomes in women with HIV type―1 receiving a lopinavir/ritonavir―containing regimen

DNA variants, plasma levels and variability of Interleukin-6 in myocardial infarction survivors: Results from the AIRGENE study

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Impact of Human Immunodeficiency Virus Type 1 Subtypes on Virologic Response and Emergence of Drug Resistance among Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

Bayesian Parameter Estimates of Nelfinavir and Its Active Metabolite, Hydroxy-tert-Butylamide, in Infants Perinatally Infected with Human Immunodeficiency Virus Type 1

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse-Transcriptase Inhibitors in HIV Type 1–Infected Children

Comparison of the conventional ‘box technique’ with two different ‘conformal’ beam arrangements for prostate cancer treatment

Increased Thymic Output after Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus Type 1–Infected Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial

Association Analysis of Drug Metabolizing Enzyme Gene Polymorphisms in AIDS Patients with Cutaneous Reactions to Sulfonamides

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial)

Aktive Filter

Suchergebnisse filtern